Replies to post #341612 on American Green Inc (ERBB)

[Saving Grace]

Exactly, big pharma pays bashers to under estimate the medicinal value and discredit stock ownership with all MJ stocks. New Legislation will prevail and allow new National Banks to back and support grow facilities and their respected products. It's a game changer that is developing.

https://www.marijuanamoment.net/feds-release-250-pages-of-redacted-documents-on-marijuana-rescheduling-recommendation-detailing-cannabiss-medical-value/

[MD420]

It has been recognized for its medicinal values.
They do have "real funding" being spent on research.
If your so enlightened by 1 article read these then
Here are 100's of thousand of pages written from researchers dating back to 18oo's[url] [tag] https://pubmed.ncbi.nlm.nih.gov/about/ [/tag] cannabis, marijuana, cannabis for pain , cannabis for etc.
35k+ research papers > Cannabis, 47k+ research papers>marijuana, people know..

How could erbb possibly benefit from this..
Are you trying too say that American Green and Stephen are not a complete fraud and think people should invest still? .
ERBB is not in the industry , they are not in any sector.
Nobody is licensed under them .
They do not manufacturer a single product in the industry.
At best they are a clothing company and have more clothes for sale then the 3 cbd items in the amazon store.
CBD items made with chinese or imported cbd ..

[Sorbytech]

Thats nothing new. If you just found this out from reading a random article, you need to read the patent on marijuana, 6630507, the United States of America as the assignee.
"Abstract: Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention..."
US government got the patent based on the neurodegenerative benefits then turned around and said there are no medical benefits of the plant.